Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-24
2011-11-01
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S019000
Reexamination Certificate
active
08048890
ABSTRACT:
Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene compounds and processes for their production, the use thereof for producing pharmaceutical compositions, pharmaceutical compositions containing these compounds and methods of treatment using these compounds.
REFERENCES:
patent: 3399192 (1968-08-01), Regnier et al.
patent: 3598828 (1971-08-01), Regnier et al.
patent: 5073560 (1991-12-01), Wu et al.
patent: 5760029 (1998-06-01), Jadhav et al.
patent: 9733887 (1997-09-01), None
patent: 9843962 (1998-10-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Buschmann Heinrich Helmut
Englberger Guenter Werner
Germann Tieno
Hennies Hagen-Heinrich
Holenz Joerg
Crowell & Moring LLP
Desai Rita
Gruenenthal GmbH
LandOfFree
Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4265432